Human Reproduction, Vol. 15, No. suppl_3, pp. 120-134, 2000
© 2000 European Society of Human Reproduction and Embryology
Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users
1 Cell Biology Unit, Christian de Duve Institute of Cellular Pathology London W6 OXG, UK 2 Department of Pathology, Saint-Luc University Clinics, Medical School of the Universite catholique de Louvain B-1200 Bruxelles, London W6 OXG, UK 3 Department of Obstetrics and Gynaecology, Centre Hospitalier Universitaire Saint-Pierre, Medical School of the Université libre de Bruxelles B-1000 Bruxelles, Belgium, London W6 OXG, UK 4 World Health Organization Collaborating Centre for Research and Reference Services in the Immunoassay of Hormones in Human Reproduction, Queen Charlotte's and Chelsea Hospital London W6 OXG, UK
Correspondence: 6To whom correspondence should be addressed at: Cell Biology Unit, Universite Catholique de Louvain, 75 Avenue Hippocrate, B-1200 Brussels, Belgium. E-mail: marbaix{at}cell.ucl.ac.be
Unpredictable endometrial bleeding is the major side-effect of levonorgestrel-releasing s.c. implants (Norplant®), otherwise a method of choice for long-term contraception. The mechanisms responsible for bleeding are still unknown and no reliable treatment is available. Several matrix metalloproteinases (MMP) are expressed and activated in human endometrium only at menstruation and specific synthetic inhibitors of MMP fully prevent the tissue breakdown that occurs in menstrual-like endometrial explants. To investigate whether MMP are inappropriately expressed and activated in Norplant-treated endometria during bleeding episodes, volunteers were recruited to provide blood and endometrial biopsies at the start of bleeding episodes and during non-bleeding intervals. Whereas serum concentrations of levonorgestrel and sex hormones showed nochange at bleeding, except for a slight decrease of oestradiol concentration, the expression and activation of stromelysin-1 released by explants cultured for 1 day were consistently increased at the start of bleeding episodes. Furthermore, stromelysin-1 was immunolocalized in stromal cells within breakdown areas of several bleeding endometria, but not in non-bleeding endometria. These observations suggest that the expression and activation of stromelysin-1 participate in the initiation of bleeding episodes upon Norplant contraception. New strategies in the prevention and treatment of abnormal bleeding based nMMP control should be envisaged.
Key words: contraception/endometrium/levonorgestrel/matrix metalloproteinase
5 Present address: PRIME/INTRAH, University of North Carolina School of Medicine, Chapel Hill, USA
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Labied, C. Galant, M. Nisolle, S. Ravet, C. Munaut, E. Marbaix, J.-M. Foidart, and F. Frankenne Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time Hum. Reprod., January 1, 2009; 24(1): 113 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.D. Catalano, H.O. Critchley, O. Heikinheimo, D.T. Baird, D. Hapangama, J.R.A. Sherwin, D.S. Charnock-Jones, S.K. Smith, and A.M. Sharkey Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium Mol. Hum. Reprod., September 1, 2007; 13(9): 641 - 654. [Abstract] [Full Text] [PDF]
|
|